Call it a case of good intentions.
The California startup Theranos Inc. has set out to revolutionize the blood-testing industry, but they hit a little snag.
The California firm wanted to revolutionize the blood-testing industry, but is now drawing blood like traditional labs
Call it a case of good intentions.
The California startup Theranos Inc. has set out to revolutionize the blood-testing industry, but they hit a little snag.